Title : p53 Gene status and response to topotecan-containing chemotherapy in advanced ovarian carcinoma.

Pub. Date : 2005

PMID : 16127286






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 OBJECTIVE: Since the p53 gene has been identified as a determinant of response to chemotherapy in ovarian carcinoma in previous studies, we investigated the significance of the p53 status in response to topotecan as second-line therapy. Topotecan tumor protein p53 Homo sapiens
2 RESULTS: Wild-type p53 tumors responsive to first-line therapy maintained substantial responsiveness to topotecan. Topotecan tumor protein p53 Homo sapiens
3 This outcome is consistent with the clinical observation that the efficacy of topotecan in the treatment of relapsed ovarian carcinoma patients is dependent on platinum sensitivity, because platinum-sensitive tumors are expected to carry wild-type p53. Topotecan tumor protein p53 Homo sapiens